-
Adcock RS, Chu Y-K, Golden JE, Chung D-H, 2017: Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay[J]. Antivir Res, 138, 47-56. doi: 10.1016/j.antiviral.2016.11.018
-
Aoki-Utsubo C, Chen M, Hotta H, 2018: Time-of-addition and temperature-shift assays to determine particular step(s) in the viral life cycle that is blocked by antiviral substance(s)[J]. BIO-Protoc, 8, e2830-.
-
Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, Rollinger JM, Schuster D, Breuss JM, Bochkov V, Mihovilovic MD, Kopp B, Bauer R, Dirsch VM, Stuppner H, 2015: Discovery and resupply of pharmacologically active plant-derived natural products:a review[J]. Biotechnol Adv, 33, 1582-1614. doi: 10.1016/j.biotechadv.2015.08.001
-
Atieh T, Baronti C, de Lamballerie X, Nougairède A, 2016: Simple reverse genetics systems for Asian and African Zika viruses[J]. Sci Rep, 6, 39384-. doi: 10.1038/srep39384
-
Aubry F, Nougairede A, de Fabritus L, Querat G, Gould EA, de Lamballerie X, 2014: Single-stranded positive-sense RNA viruses generated in days using infectious subgenomic amplicons[J]. J Gen Virol, 95, 2462-2467. doi: 10.1099/vir.0.068023-0
-
Barrows NJ, Campos RK, Powell ST, Prasanth KR, Schott-Lerner G, Soto-Acosta R, Galarza-Munoz G, McGrath EL, Urrabaz-Garza R, Gao J, Wu P, Menon R, Saade G, Fernandez-Salas I, Rossi SL, Vasilakis N, Routh A, Bradrick SS, Garcia-Blanco MA, 2016: A Screen of FDA-approved drugs for inhibitors of Zika virus infection[J]. Cell Host Microbe, 20, 259-270. doi: 10.1016/j.chom.2016.07.004
-
Chen Y, Hu Y, Michaels S, Segal D, Brown D, Li S, 2009: Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice[J]. Leukemia, 23, 1446-1454. doi: 10.1038/leu.2009.52
-
Chen M, Aoki-Utsubo C, Kameoka M, Deng L, Terada Y, Kamitani W, Sato K, Koyanagi Y, Hijikata M, Shindo K, Noda T, Kohara M, Hotta H, 2017: Broad-spectrum antiviral agents:secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane[J]. Sci Rep, 7, 15931-. doi: 10.1038/s41598-017-16130-w
-
Chen X, Tang Y, Chen J, Chen R, Gu L, Xue H, Pan C, Tang J, Shen S, 2019: Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia[J]. Front Med, 13, 378-387. doi: 10.1007/s11684-018-0658-4
-
Chitti SV, Prasad AK, Saxena SK, 2016: Emerging Zika virus disease:a public health emergency of global concern[J]. VirusDisease, 27, 211-214. doi: 10.1007/s13337-016-0317-9
-
Cragg GM, Newman DJ, 2013: Natural products:a continuing source of novel drug leads[J]. Biochim Biophys Acta, 1830, 3670-3695. doi: 10.1016/j.bbagen.2013.02.008
-
Davis CW, Nguyen H-Y, Hanna SL, Sanchez MD, Doms RW, Pierson TC, 2006: West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection[J]. J Virol, 80, 1290-1301. doi: 10.1128/JVI.80.3.1290-1301.2006
-
Delvecchio R, Higa L, Pezzuto P, Valadão A, Garcez P, Monteiro F, Loiola E, Dias A, Silva F, Aliota M, Caine E, Osorio J, Bellio M, O'Connor D, Rehen S, de Aguiar R, Savarino A, Campanati L, Tanuri A, 2016: Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models[J]. Viruses, 8, 322-. doi: 10.3390/v8120322
-
Deng C-L, Zhang Q-Y, Chen D-D, Liu S-Q, Qin C-F, Zhang B, Ye H-Q, 2017: Recovery of the Zika virus through an in vitro ligation approach[J]. J Gen Virol, 98, 1739-1743. doi: 10.1099/jgv.0.000862
-
Dick GWA, Kitchen SF, Haddow AJ, 1952: Zika virus (I) Isolations and serological specificity[J]. Trans R Soc Trop Med Hyg, 46, 509-520. doi: 10.1016/0035-9203(52)90042-4
-
Dong H-J, Wang Z-H, Meng W, Li C-C, Hu Y-X, Zhou L, Wang X-J, 2018: The natural compound homoharringtonine presents broad antiviral activity in vitro and in vivo[J]. Viruses, 10, 601-. doi: 10.3390/v10110601
-
Fernandez-Garcia M-D, Mazzon M, Jacobs M, Amara A, 2009: Pathogenesis of Flavivirus infections:using and abusing the host cell[J]. Cell Host Microbe, 5, 318-328. doi: 10.1016/j.chom.2009.04.001
-
França GVA, Schuler-Faccini L, Oliveira WK, Henriques CMP, Carmo EH, Pedi VD, Nunes ML, Castro MC, Serruya S, Silveira MF, Barros FC, Victora CG, 2016: Congenital Zika virus syndrome in Brazil:a case series of the first 1501 livebirths with complete investigation[J]. Lancet, 388, 891-897. doi: 10.1016/S0140-6736(16)30902-3
-
Gadea G, Bos S, Krejbich-Trotot P, Clain E, Viranaicken W, El-Kalamouni C, Mavingui P, Despres P, 2016: A robust method for the rapid generation of recombinant Zika virus expressing the GFP reporter gene[J]. Virology, 497, 157-162. doi: 10.1016/j.virol.2016.07.015
-
Gulland A (2016) Zika virus is a global public health emergency, declares WHO. BMJ i657
-
Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N, Perera-Lecoin M, Surasombatpattana P, Talignani L, Thomas F, Cao-Lormeau V-M, Choumet V, Briant L, Desprès P, Amara A, Yssel H, Missé D, 2015: Biology of Zika virus infection in human skin cells[J]. J Virol, 89, 8880-8896. doi: 10.1128/JVI.00354-15
-
Hua R-H, Huo H, Li Y-N, Xue Y, Wang X-L, Guo L-P, Zhou B, Song Y, Bu Z-G, 2014: Generation and efficacy evaluation of recombinant classical Swine fever virus E2 glycoprotein expressed in stable transgenic mammalian cell line[J]. PLoS ONE, 9, e106891-. doi: 10.1371/journal.pone.0106891
-
Hua RH, Li YN, Chen ZS, Liu LK, Huo H, Wang XL, Guo LP, Shen N, Wang JF, Bu ZG, 2014: Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate[J]. BMC Biotechnol, 14, 62-. doi: 10.1186/1472-6750-14-62
-
Jin J, Jiang DZ, Mai WY, Meng HT, Qian WB, Tong HY, Huang J, Mao LP, Tong Y, Wang L, Chen ZM, Xu WL, 2006: Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia[J]. Leukemia, 20, 1361-1367. doi: 10.1038/sj.leu.2404287
-
Kingston DGI, 2011: Modern natural products drug discovery and its relevance to biodiversity conservation[J]. J Nat Prod, 74, 496-511. doi: 10.1021/np100550t
-
Kobayashi S, Yoshii K, Hirano M, Muto M, Kariwa H, 2017: A novel reverse genetics system for production of infectious West Nile virus using homologous recombination in mammalian cells[J]. J Virol Methods, 240, 14-20. doi: 10.1016/j.jviromet.2016.11.006
-
Li C, Zhu X, Ji X, Quanquin N, Deng YQ, Tian M, Aliyari R, Zuo X, Yuan L, Afridi SK, Li XF, Jung JU, Nielsen-Saines K, Qin FX, Qin CF, Xu Z, Cheng G, 2017: Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice[J]. EBioMedicine, 24, 189-194. doi: 10.1016/j.ebiom.2017.09.034
-
Li W, Ma L, Guo L-P, Wang X-L, Zhang J-W, Bu Z-G, Hua R-H, 2017: West Nile virus infectious replicon particles generated using a packaging-restricted cell line is a safe reporter system[J]. Sci Rep, 7, 3286-. doi: 10.1038/s41598-017-03670-4
-
Lo MK, Tilgner M, Shi P-Y, 2003: Potential high-throughput assay for screening inhibitors of West Nile virus replication[J]. J Virol, 77, 12901-12906. doi: 10.1128/JVI.77.23.12901-12906.2003
-
Lü S, Wang J, 2014: Homoharringtonine and omacetaxine for myeloid hematological malignancies[J]. J Hematol OncolJ Hematol Oncol, 7, 2-. doi: 10.1186/1756-8722-7-2
-
Münster M, Płaszczyca A, Cortese M, Neufeldt C, Goellner S, Long G, Bartenschlager R, 2018: A reverse genetics system for Zika virus based on a simple molecular cloning strategy[J]. Viruses, 10, 368-. doi: 10.3390/v10070368
-
Petersen EE, Staples JE, Meaney-Delman D, Fischer M, Ellington SR, Callaghan WM, Jamieson DJ, 2016: Interim guidelines for pregnant women during a Zika virus outbreak-United States, 2016[J]. MMWR Morb Mortal Wkly Rep, 65, 30-33. doi: 10.15585/mmwr.mm6502e1
-
Pu SY, Wu RH, Yang CC, Jao TM, Tsai MH, Wang JC, Lin HM, Chao YS, Yueh A, 2011: Successful propagation of Flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes[J]. J Virol, 85, 2927-2941. doi: 10.1128/JVI.01986-10
-
Schwarz MC, Sourisseau M, Espino MM, Gray ES, Chambers MT, Tortorella D, Evans MJ (2016) Rescue of the 1947 Zika virus prototype strain with a cytomegalovirus promoter-driven cDNA clone. mSphere 1
-
Shan C, Xie X, Muruato Antonio E, Rossi Shannan L, Roundy Christopher M, Azar Sasha R, Yang Y, Tesh Robert B, Bourne N, Barrett Alan D, Vasilakis N, Weaver Scott C, Shi P-Y, 2016: An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors[J]. Cell Host Microbe, 19, 891-900. doi: 10.1016/j.chom.2016.05.004
-
Shimojima M, Takenouchi A, Shimoda H, Kimura N, Maeda K, 2014: Distinct usage of three C-type lectins by Japanese encephalitis virus:DC-SIGN, DC-SIGNR, and LSECtin[J]. Adv Virol, 159, 2023-2031.
-
Tsetsarkin KA, Kenney H, Chen R, Liu G, Manukyan H, Whitehead SS, Laassri M, Chumakov K, Pletnev AG, 2016: A full-length infectious cDNA clone of Zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development[J]. mBio, 7, -.
-
Veeresham C, 2012: Natural products derived from plants as a source of drugs[J]. J Adv Pharm Technol Res, 3, 200-. doi: 10.4103/2231-4040.104709
-
Weger-Lucarelli J, Duggal NK, Bullard-Feibelman K, Veselinovic M, Romo H, Nguyen C, Ruckert C, Brault AC, Bowen RA, Stenglein M, Geiss BJ, Ebel GD, 2017: Development and characterization of recombinant virus generated from a new world Zika virus infectious clone[J]. J Virol, 91, -.
-
Widman DG, Young E, Yount BL, Plante KS, Gallichotte EN, Carbaugh DL, Peck KM, Plante J, Swanstrom J, Heise MT, Lazear HM, Baric RS, 2017: A Reverse genetics platform that spans the Zika virus family tree[J]. mBio, 8, -.
-
Xie X, Zou J, Shan C, Yang Y, Kum DB, Dallmeier K, Neyts J, Shi PY, 2016: Zika virus replicons for drug discovery[J]. EBioMedicine, 12, 156-160. doi: 10.1016/j.ebiom.2016.09.013
-
Xu M, Lee EM, Wen Z, Cheng Y, Huang W-K, Qian X, Tcw J, Kouznetsova J, Ogden SC, Hammack C, Jacob F, Nguyen HN, Itkin M, Hanna C, Shinn P, Allen C, Michael SG, Simeonov A, Huang W, Christian KM, Goate A, Brennand KJ, Huang R, Xia M, Ming G-l, Zheng W, Song H, Tang H, 2016: Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen[J]. Nat Med, 22, 1101-1107. doi: 10.1038/nm.4184
-
Yang Y, Shan C, Zou J, Muruato AE, Bruno DN, de Almeida Medeiros Daniele B, Vasconcelos PFC, Rossi SL, Weaver SC, Xie X, Shi P-Y, 2017: A cDNA clone-launched platform for high-yield production of inactivated Zika vaccine[J]. EBioMedicine, 17, 145-156. doi: 10.1016/j.ebiom.2017.02.003
-
Zheng X, Tong W, Liu F, Liang C, Gao F, Li G, Tong G, Zheng H, 2016: Genetic instability of Japanese encephalitis virus cDNA clones propagated in Escherichia coli[J]. Virus Genes, 52, 195-203. doi: 10.1007/s11262-016-1289-y